These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16902174)

  • 1. Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1.
    Wilczak N; Elting JW; Chesik D; Kema IP; De Keyser J
    Stroke; 2006 Sep; 37(9):2368-71. PubMed ID: 16902174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
    Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke.
    Ebinger M; Ipsen N; Leonards CO; Empl L; Hanne L; Liman T; Mai K; Strasburger CJ; Spranger J; Endres M
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):461-5. PubMed ID: 26069074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
    Lindley RI
    Stroke; 2009 Jul; 40(7):2613-4. PubMed ID: 19443793
    [No Abstract]   [Full Text] [Related]  

  • 10. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Corbo M; Lunetta C; Magni P; Dozio E; Ruscica M; Adobbati L; Silani V
    Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department.
    ;
    Ann Emerg Med; 2013 Feb; 61(2):225-43. PubMed ID: 23331647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decompressive craniectomy after intravenous tissue plasminogen activator administration for stroke.
    Takeuchi S; Wada K; Nawashiro H; Arimoto H; Ohkawa H; Masaoka H; Otani N; Takasato Y
    Clin Neurol Neurosurg; 2012 Dec; 114(10):1312-5. PubMed ID: 22502785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 15. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
    Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
    Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
    Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
    Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
    Denti L; Annoni V; Cattadori E; Salvagnini MA; Visioli S; Merli MF; Corradi F; Ceresini G; Valenti G; Hoffman AR; Ceda GP
    Am J Med; 2004 Sep; 117(5):312-7. PubMed ID: 15336580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.
    Ginsberg MD; Hill MD; Palesch YY; Ryckborst KJ; Tamariz D
    Stroke; 2006 Aug; 37(8):2100-6. PubMed ID: 16809571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO; Blum WF; Møller N; Ranke MB; Christiansen JS
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.